Doctor Shengyuan Luo
The Johns Hopkins University School of Medicine, Baltimore (United States of America)
Follow
Biography
Cardiologist. Cardiovascular disease researcher. Clinical epidemiologist.
Contributor content
Presentation
Soluble urokinase-type plasminogen activator receptor (suPAR) is associated with risk for thromboembolic complications and mortality in patients with COVID-19
Presentation
